First trimester placental growth factor in maternal blood and placenta related disorders

References

• Garcia S, Tayyar A, Poon L, et al. Competing risks model in screening for preeclampsia by biophysical and biochemical markers at 30–33 weeks' gestation. Fetal Diagn Ther. 2014;36(1):9–17.
   PubMed Web of Science ®Google Scholar
• Poon LC, Nicolaides KH. First-trimester maternal factors and biomarker screening for preeclampsia. Prenat Diagn. 2014;34(7):618–627.
   PubMed Web of Science ®Google Scholar
• Conde-Agudelo A, Belizán JM. Risk factors for preeclampsia in a large cohort of Latin American and Caribbean women. BJOG. 2000;107(1):75–83.
   PubMed Web of Science ®Google Scholar
• Tsiakkas A, Duvdevani N, Wright A, et al. Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol. 2015;45(5):591–598.
   PubMed Web of Science ®Google Scholar
• Panaitescu AM, Akolekar R, Kametas N, et al. Impaired placentation in women with chronic hypertension who develop pre-eclampsia. Ultrasound Obstet Gynecol. 2017;50(4):496–500.
   PubMed Web of Science ®Google Scholar
• O'Gorman N, Wright D, Poon LC, et al. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation: comparison with NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol. 2017;49(6):756–760.
   PubMed Web of Science ®Google Scholar
• Charas YT, Liao AW, Cacho AM, et al. First-trimester maternal serum levels of placenta growth factor as predictor of preeclampsia and fetal growth restriction. Obstet Gynecol. 2001;98:608–611.
   PubMed Web of Science ®Google Scholar
• Chau K, Hennessy A, Makris A. Placental growth factor and pre-eclampsia. J Hum Hypertens. 2017;31(12):782–786.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Chaudhary S, Kar R, et al. Prediction of preeclampsia in primigravida in late first trimester using serum placental growth factor alone and by combination model. J Obstet Gynaecol. 2017;37(7):877–882.
   PubMedGoogle Scholar
• Agudelo ML, Agudelo LM, Castaño JJ, et al. Prevalencia de los trastornos hipertensivos del embarazo en mujeres embarazadas controladas en ASSBABASALUD E.S.E, Manizales (Colombia), 2006–2008. Archivos de Medicina – Universidad de Manizales. 2010;10(2). DOI:10.30554/archmed.10.2.1293.2010.
   Google Scholar
• Secretaria distrital de salud. Guía de trastornos hipertensivos del embarazo. Bogota: Alcaldía Mayor de Bogotá D.C, Secretaria distrital de salud; 2014.
   Google Scholar
• Uriel M, Romero XC. Reality of preeclampsia in Colombian pregnant women. J Gynecol. 2016;1(1):000105.
   Google Scholar
• Romero XC, Gutiérrez AM, Rojas NA, et al. Incidencia De los trastornos hipertensivos En El embarazo, Y características Clínico-Demográficas En tres instituciones en bogotá, D.C., Colombia. Investigaciones en Seguridad Social y Salud. 2018;20:21–30.
   Google Scholar
• Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122–1131. DOI: 10.1097/01.AOG.0000437382.03963.88.
   Google Scholar
• America College of Obstetricians and Gynecologists. ACOG practice bulletin no. 204: Fetal growth restriction. Obstet Gynecol. 2019;133:e97–e109.
   PubMedGoogle Scholar
• Blue NR, Beddow ME, Savabi M, et al. A comparison of methods for the diagnosis of fetal growth restriction between the Royal College of Obstetricians and Gynaecologists and the American College of Obstetricians and Gynecologists. Obstet Gynecol. 2018;131(5):835–841.
   PubMed Web of Science ®Google Scholar
• World Medical Association. WMA Declaration of Helsinki – ethical principles for medical research involving human subjects. Adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964; 2018. Avaialble from: WMA website: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/
   Google Scholar
• de Salud M. Resolución 8430 de 1993. Por la cual se establecen las normas científicas, técnicas y administrativas para la investigación en salud. Octubre 4 de 1993.
   Google Scholar
• Anderson UD, Olsson MG, Kristensen KH, et al. Review: biochemical markers to predict preeclampsia. Placenta. 2012;33:S42–S547.
   PubMed Web of Science ®Google Scholar
• Jasovic-Siveska E. Clinical and biochemical markers for preeclampsia. Obstet Gynecol Int. 2017;6(2):00198.
   Google Scholar
• Kasdaglis G, Aberdeen G, Turan O, et al. Placental growth factor in the first trimester: relationship with maternal factors and placental Doppler studies. Ultrasound Obstet Gynecol. 2010;35(3):280–285.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Chaudhary S, Kar R, et al. Serum placental growth factor in late first trimester of pregnancy for prediction of preeclampsia in primiravida – a case control study. Int J Reprod Contracept Obstet Gynecol. 2016;6(1):106–110.
   Google Scholar
• Ahumada JS, Barrera AM, Canosa D, Cárdenas L, Uriel M, Ibáñez EA, et al. Factores de riesgo de parto pretérmino en Bogotá D.C., Colombia. (Spanish). Revista Facultad de Medicina de la Universidad Nacional de Colombia [Internet]. 2020;68(4):556–563.
   Google Scholar
• Zhong Y, Tuuli M, Odibo AO. First-trimester assessment of placenta function and the prediction of preeclampsia and intrauterine growth restriction. Prenat Diagn. 2010;30(4):293–308.
   PubMed Web of Science ®Google Scholar
• Akolekar R, Syngelaki A, Sarquis R, et al. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks . Prenat Diagn. 2011;31(1):66–74.
   PubMed Web of Science ®Google Scholar
• Akolekar R, Zaragoza E, Poon LCY, et al. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2008;32(6):732–739.
   PubMed Web of Science ®Google Scholar
• Noroña CD. Preeclampsia: biochemical markers age. Rev Cient Cienc Med. 2014;17(2):32–38.
   Google Scholar
• Benton SJ, McCowan LM, Heazell AEP, et al. Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction. Placenta. 2016;42:1–8.
   PubMed Web of Science ®Google Scholar